Expert opinion on neuraminidase inhibitors for the prevention and treatment of influenza - review of recent systematic reviews and meta-analyses
This ECDC expert opinion confirms earlier assessments by ECDC and national authorities that there is no significant new evidence to support any changes to the approved indications and recommended use of neuraminidase inhibitors (NAIs) in EU/EEA Member States.
Effectiveness of screening and treatment approaches for schistosomiasis and strongyloidiasis in newly-arrived migrants from endemic countries in the EU/EEA: A systematic review
Agbata, E.N., Morton, R.L., Bisoffi, Z., Bottieau, E., Greenaway, C., Biggs, B., Montero, N., Tran, A., Rowbotham, N., Arevalo-Rodriguez, I., Myran, D.T., Noori, T., Alonso-Coello, P., Pottie, K., Requena-Méndez, A.
Antibiotic resistance in Europe: the challenges ahead
Monnet, D.L., Suetens, C., Buksarova, A., Earnshaw, S., Gagliotti, C., Heuer, O., Magiorakos, A.P., Mantero, J., Marma, S., Navarro, Torne, A., Sodano, L., Weber, J.T., Weist, K.
Q fever in humans and farm animals in four European countries, 1982 to 2010
Georgiev, M., Afonso, A., Neubauer, H.,Needham, H.,Thiery, R., Rodolakis, A., Roest, H.J., Stark, K.D., Stegeman, J.A., Vellema, P., van der Hoek, W., More, S.J.,
No new human infections with A/H5N1 in Turkey but national measures and international support continue.